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Placentalinsuﬃciency(PI)prevents adequate delivery ofnutrients to thedeveloping fetus andcreates a chronic stateof hypoxemia
and hypoglycemia. In response, the malnourished fetus develops a series of stress hormone-mediated metabolic adaptations
to preserve glucose for vital tissues at the expense of somatic growth. Catecholamines suppress insulin secretion to promote
glucose sparing forinsulin-independent tissues (brain,nerves) over insulin-dependent tissues (skeletal muscle,liver, andadipose).
Likewise, premature induction of hepatic gluconeogenesis helps maintain fetal glucose and appears to be stimulated by both
norepinephrine and glucagon. Reduced glucose oxidation rate in PI fetuses creates a surplus of glycolysis-derived lactate that
serves as substrate for hepatic gluconeogenesis. These adrenergically inﬂuenced adaptive responses promote in utero survival but
also cause asymmetric intrauterine growth restriction and small-for-gestational-age infants that are at greater risk for serious
metabolic disorders throughout postnatal life, including obesity and type II diabetes.
1.Introduction
Placental insuﬃciency (PI) is a common cause of fetal mal-
nutritionthatmanifestsintosmall-for-gestational-age (SGA)
infants [1]. Poor nutrient supply necessitates metabolic
adaptations by the fetus that result in asymmetrical
intrauterine growthrestriction (IUGR)[2–4]. Althoughspe-
ciﬁc etiology of PI is rarely determined and is likely case-
speciﬁc, common results of placental dysfunction include
fetal hypoxemia and hypoglycemia that worsen in concert
with increasing fetal demands over the last half of gestation,
causing hypercatecholaminemia and hypoinsulinemia [4–
7]. Parallels for characteristics observed in human PI-IUGR
fetuses have been demonstrated in an ovine model of
hyperthermia-induced PI [8]. Similar to humans, body mass
in ovine PI-IUGR fetuses is normal at the end of the ﬁrst
trimester but is reduced by 25% at the end of the second
trimester [9, 10] and by over 50% near term [11]. Restricted,
asymmetrical growth is a consequence of adaptive responses
that support critical organ development at the expense of
somatic growth [10]. Epidemiological ﬁndings have linked
PI-induced alterationof fetal metabolic phenotypeto greater
incidence of postnatal metabolic complications such as
hypertension [12], obesity [13], and type II diabetes [14–
16]. The hyperthermia-induced ovine model of PI-IUGR
provides an in vivo system for conducting comparative
physiological studies of fetal developmental adaptations
during pathophysiology [8]. This paper highlights ﬁndings
regarding fetal adaptive responses learned from this ovine
model of PI-IUGR.
2.ExperimentalPlacentalInsufﬁciency:
The HyperthermicOvine Model
Hyperthermically induced PI-IUGR has been compared to
other forms of IUGR induction in sheep, and advantages
of this model have been described [8, 17]. To induce PI,
pregnant ewes are placed in environmentally controlled
chambers beginning at the 40th day of gestation (dGA; term
is 147 dGA) and exposed to elevated ambient temperatures
in a diurnal pattern of 40◦C for 12 hours and 35◦Cf o r1 22 Journal of Pregnancy
hours (dew point 22◦C; relative humidity 35–45%) for 55
consecutive days, though severity of growth restriction may
be reduced by decreasing duration of exposure [18]. In
concert with high ambient temperatures, ewes exhibit a 0.7–
1.0◦C rise in core body temperature [19, 20]. This febrile
response is a hypothesized source of vasopressin-mediated
reduction in maternal blood ﬂow to the uterus [19], which
slows placental growth and development. A smaller, less
metabolically active placenta beneﬁts the hyperthermically
stressed dam by producing less heat and requiring fewer
nutrients, but the trade-oﬀ of stunted growth and develop-
ment is a placenta that cannot adequately meet nutritional
demandsofthegrowing fetusinlaterstagesofgestation[21].
Ewes exposed to hyperthermic conditions described
above exhibit slightly lighter placentas than pair-fed ther-
moneutral contemporaries beginning at approximately 75
dGA (∼0.5 gestation), but the disparity between normal and
compromised placentas worsens with increasing gestational
age and mass may diﬀer by as much as 66% at term [18, 22].
Reduced placental mass results from less total tissue and
smaller, rather than fewer placentomes [18, 22, 23]. Addi-
tionally, cotyledons, the fetal tissue in placentomes, exhibit
poor vascular organization [24]. In normal pregnancies,
the need for oxygen within the growing placenta stimulates
release of vascular endothelial growth factor (VEGF) to
promote branching angiogenesis [25]. Angiogenic growth
factors are responsible for the 10-fold increase in capillary
area density and 14-fold increase in total villous surface area
that occurs between early and late gestation [26]. However,
whenoxygencontentwithin theearly stageplacentabecomes
abnormally low due to reduced uterine blood ﬂow, a
premature spike in VEGF disrupts the intended progression
ofvasculargenesis[27]andmayresultinaperiodofplacental
hyperoxia [10, 28, 29]. In this hyperoxic state, the incentive
to secrete angiogenic growth factors is lost, resulting in
underdevelopmentof placental vasculature structure [29].
3.PlacentalInsufﬁciencyCauses
Fetal Malnutrition
Increased oxygen and glucose gradients between maternal
and fetal circulation are hallmarks of PI, and appear to
helppromotetransplacental diﬀusion[23,30–32](Figure 1).
Nevertheless, umbilical oxygen content is diminished by as
much as 50% following hyperthermically induced PI at 0.9
of gestation [31], despite normal oxygen concentrations in
uterine blood. Oxygen exchange between maternal and fetal
circulationoccursby simple diﬀusion and without assistance
from specialized transporters. Thus, oxygen transport rate
across the placenta is determined by perfusion rate, placental
surface area, and distance between maternal and fetal
vasculature. Smaller placental mass and vascular disorgani-
zation contribute to reduced oxygen exchange but may be
partially oﬀset by reduced thickness of tissue and increased
transplacental gradient so that absolute umbilical oxygen
uptake and content are reduced after hyperthermic insult
even though umbilical oxygen uptake per unit of placental
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Figure 1: Increased transplacental oxygen and glucose gradi-
ents appear to partially ameliorate rates of umbilical uptake in
hyperthermia-induced PI-IUGR fetuses (black symbols) compared
to uncompromisedfetuses (white symbols).Data are from Thureen
et al. [23] (diamonds), Limesand et al. [30] (squares) and [31]
(circles), and De Vrijer et al. [32]( t r i a n g l e s ) .
mass is similar between hyperthermic and thermoneutral
animals [23, 31, 33, 34].
Umbilical vein glucose concentrations are also approxi-
mately 50% lower in PI-IUGR fetuses during late gestation
[23, 33]. Unlike placental oxygen transport, placental glu-
cose exchange requires facilitative glucose transporters for
transfer of glucose down its maternal-to-fetal concentration
gradient(Figure 2). Althoughless placental mass and surface
area contributes to reduced absolute glucose transport,
placental glucose transport per unit of placental mass is
also lower. The later observation is associated with reduced
expression of glucose transporter transcripts 1, 3, and 8 [30,
33],whichwerepreviouslyidentiﬁedinovineplacentaltissue
[30, 35, 36].
Umbilical uptake of amino acid is also diminished (23%
and 58% in absolute uptake and uptake per unit of placental
mass,r e s p . )[ 32,37, 38],likelyduetoreducedplacentalmass,
surface area, and transporter expression (Figure 3). Because
amino acids are actively transported and may be utilized orJournal of Pregnancy 3
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Figure 2: A schematic representation of glucose transfer across normaland PI-IUGR placenta. Facilitated diﬀusion of glucose occurs down
its concentration gradient through membrane-bound GLUT transporters in normal and compromised placentas. Values are from Regnault
et al. [11].
otherwise altered by the placenta, ﬂux occurs in several
directions simultaneously: maternal → fetal circulation
(direct), maternal ↔ placenta, and placenta ↔ fetal [39].
The rate of each ﬂux is amino acid speciﬁc, and severity
of reduced transport depends largely on which of several
transport systems is the primary facilitator of that amino
acid. Though not yet deﬁned in the ovine PI-IUGR, Systems
A, y+, and X
−
AG are most profoundly aﬀected in rat models
[40, 41].
Fetal nutrient and oxygen requirements increase with
growth and eventually surpass the capacity at which the
compromised placenta can deliver oxygen and glucose
to the fetus, creating a chronic state of hypoxemia and
hypoglycemia that progressively worsens over the last half of
gestation [11, 42]. PI-induced malnutrition elicits adaptive
responses by the fetus that alter its physiological proﬁle to
support the most vital tissues at the expense of normal
growth and development [43, 44].
4.Fetal MalnutritionCauses
Hormone-MediatedAdaptiveResponses
Fetal adaptations to PI-induced hypoxemia and hypo-
glycemia are mediated by endocrine responses (Table 1).
Secretion of the catecholamines, norepinephrine and
epinephrine, from the adrenal medulla, increases drastically
in response to hypoxemia [45]. In addition to hypothalamic
stimulation via the splanchnic nerve during later gestation,
low oxemic levels stimulate chromaﬃn cells of the medulla
directly via inactivation of oxygen-sensitive potassium
channels [46] .T h ec h a n g ei np o t a s s i u mc o n c e n t r a t i o n
favors membrane depolarization needed for catecholamine
exocytosis. Both norepinephrine [47] and epinephrine [48]
are secreted in response to moderate fetal hypoxemia (12–
18mmHg), but epinephrine secretion is increased in greater
proportion [49, 50], especially after splanchnic innervation
develops [51]. Catecholamines appear to be primary
mediating factors in maintaining glucose supply in the PI-
IUGR by suppressing insulin secretion and altering the fetal
metabolic phenotype (discussed in detail below). However,
adenosine concentration within the interstitial ﬂuid of
neural and skeletal muscle tissue also increases during
fetal hypoxemia and, although not traditionally considered
a hormone, has been shown to elicit many of the same
responses as catecholamines [52, 53]. Also, hypoglycemia-
stimulated cortisol secretion from the adrenal cortex has
beenobservedintheovine fetus[54,55],though stimulation
during hyperthermia-induced PI-IUGR is debatable.
By binding and activating α2-adrenergic receptors on
pancreatic β cells, catecholamines suppress insulin secretion
and may reduce plasma insulin concentrations by ∼5-fold in
PI-IUGR [42] while glucagon secretion from pancreatic α-
cells increases [56]. During chronic hypoinsulinemia, neural4 Journal of Pregnancy
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Figure 3: Amino acid ﬂuxes between maternal circulation, placental tissue, and fetal circulation. Values are from Ross et al. [38]a n d
Anderson et al. [37].
Table 1: Hormoneproﬁles in ovine and human PI-IUGR fetuses and neonates.1
Hormone Ovine Human
Prenatal Neonatal2 Prenatal Neonatal3
Control IUGR Control IUGR Control IUGR Control IUGR
Norepinephrine, pg/mL 636 2564 1073 ? 132 1031 65004 74004
Epinephrine, pg/mL Below detection <40 394 ? Below detection <180 3604 3804
Cortisol, ng/mL 4.4 4.4 28 19 1.66 1.13 1.24 0.96
Basal insulin, ng/mL 0.28 0.09 0.74 0.73 0.98 0.54 0.48 0.48
GSIS insulin, ng/mL 0.60 0.14 4.16 8.05 4.91 0.58 2.15 3.83
Glucagon, pg/mL 39.8 79.0 139 ? 133 259 87 78
1Data from [4, 6, 56–68] (S. W. Limesand, unpublished).
2Preruminal lambs, 8–21 days of age.
3Infants, <1yrofage.
4Measured in urine samples,normalized to creatinine concentration.
tissues, which are insulin independent, have a competitive
advantage over tissues that rely on insulin-mediated uptake,
such as liver, skeletal muscle, and adipose tissue. More-
over, GLUT1 transporters are upregulated in the brain to
facilitate crucial glucose uptake at the expense of systemic
growth [31, 69, 70]. Skeletal muscle cells enhance sensitivity
to chronically low insulin by increasing insulin receptor
concentrations, which restores glucose uptake [56, 71].
However, since glucose oxidation rates are depressed in
the PI-IUGR fetus [31], enhanced insulin sensitivity in
skeletal muscle likely restores glucose uptake for anaerobic
metabolism and not oxidative energy production. Muscle
cellsappeartocopewith catecholamine-mediated restriction
of glucose oxidation through several mechanisms (Figure 4).
Increased systemic oxidation rate of amino acids has been
demonstrated in both PI-IUGR and experimentally hypo-
glycemic fetuses [37, 38, 72], indicating that muscle cells
are relying on alternative substrates for oxidative energy
production. Utilization of free fatty acids for energy is
thought to be minimal in the uncompromised ovine fetus
[73], but elevated catecholamines increase mobilization and
β-oxidation in infantile lambs [57] and may promote similar
use of fat in the late-term PI-IUGR fetus, though utilization
by skeletal muscle has yet to be examined in this model.
Consumption of amino acids for energy production coupled
with reduced net inﬂux from maternal circulation restricts
proteinaccretionand musculargrowthin thePI-IUGRfetus.
The metabolic end product of anaerobic glucose
metabolism, lactate, can exit muscle cells into circulation. In
addition to being observed in PI-IUGR fetuses [31], elevatedJournal of Pregnancy 5
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Figure 4: Proposed changes in metabolic phenotype of skeletal muscle in growth-restricted fetuses with placental insuﬃciency. Changes
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Figure 5: Glucose production by the liver occurs in placental insuﬃciency-induced growth-restricted fetuses to maintain glucose supply to
vital tissues. Stress hormonesinitiate transcriptional cofactors responsible for expression of gluconeogenic enzymes. Lactate from anaerobic
metabolism and amino acids from protein breakdown are gluconeogenic substrates, while fatty acids from adipose breakdown are converted
to ketone bodies, which provide energy to neural tissue.6 Journal of Pregnancy
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Figure 6: Increased uterine-to-umbilical blood ﬂow ratios are
needed to partially recover umbilical uptake rates in hyperthermia-
induced PI-IUGR fetuses (black symbols) compared to uncompro-
mised fetuses (white symbols). Data are from Thureen et al. [23]
(diamonds), Limesand et al. [30] (squares) and [31]( c i r c l e s ) ,a n d
De Vrijer et al. [32]( t r i a n g l e s ) .
plasma lactate concentrations have also been observed dur-
ingacutecatecholamineandadenosineinfusionintouncom-
promised ovine fetuses [52, 74], indicating a regulatory role
for these compounds. During PI, lactate becomes a crucial
substrate for glycogen synthesis in cardiac tissue [75]a n d ,i n
a process known as the Cori cycle, serves as a precursor for
hepatic gluconeogenesis, along with amino acids and other
substrates (Figure 5). In normal, well-nourished fetuses,
gluconeogenesis does not develop until the ﬁnal days of
gestation in anticipation of postnatal life [76–78]. In the
PI-IUGR, however, stress hormones appear to encourage
much earlier establishment of hepatic glucose production by
upregulating two major gluconeogenic enzymes, glucose-6-
phosphatase(G6P)andphosphoenolpyruvatecarboxykinase
(PEPCK) [31, 78, 79], in part through increased levels of
relevant transcriptional factors and coactivators [31, 54, 79].
Hepatic gluconeogenesis is crucial to maintaining the fetal
glucose pool and likely preserves glycogen stores in muscle
andlivertissues[31].Aﬁnal catecholamine-mediated energy
source for neural tissue in the PI-IUGR fetus appears to be
provided by conversion of mobilized fatty acids to ketone
bodies by the liver, although this has not been demonstrated
in the hyperthermic ovine model.
In addition to metabolic changes, fetal blood ﬂow is
altered in PI-IUGR fetuses. Near term, blood ﬂow to the
brain and heart of hyperthermic fetuses is increased by
50% and 8%, respectively, at the expense of ﬂow to the
liver, lungs, small intestine, pancreas, and adipose tissue,
which decreases noticeably [80, 81]. Additionally, slower
rate of umbilical blood ﬂow caused by increased resistance
[82] increases transplacental oxygen and glucose gradients,
aiding extraction from maternal circulation [32, 34, 83, 84]
(Figure 6).
5.AdaptiveResponsesCause
Postnatal Consequences
Fetal adaptive responses to PI cause SGA oﬀspring to
be at greater risk for postnatal metabolic complications
due in large part to altered sensitivities of tissues to
stress hormones and other stimulants. Chronically elevated
fetal catecholamines eventually desensitize adipose tissue by
downregulation of β2 adrenergic receptors, which impairs
fat mobilization and promotes adiposity in PI-IUGR lambs
[57]. Similarly, chronic adrenergic suppression of pancre-
atic β-cells causes compensatory adaptations that result in
hypersensitivity to glucose stimulation and appear to cause
oversecretion of insulin in the neonatal lamb (Limesand,
unpublished data). This, coupled with enhanced sensitivity
to insulin in skeletal muscle due to chronic hypoinsulinemia
[56, 71], may increase propensity for glucose to be stored
as fat during “catch-up” growth and predispose oﬀspring
to childhood obesity. Fetal adaptive responses are also
reﬂected in aberrant anatomy of the pancreas. Glucagon-
producing pancreatic α-cells exhibit normal responsiveness
and morphometrics [56], but β-cells may be reduced in
mass by as much as 75% in the PI-IUGR due to lower
replication rate [85]. Correspondingly, fetal islets contain
80% less insulin content and are less able to induce glucose
oxidative metabolism [31, 56]. Thus, the ability to synthesize
and store insulin in pancreatic islets is reduced, though
t h ea b i l i t yt os e c r e t ew h a ti n s u l i ni sa v a i l a b l ei nr e s p o n s e
to stimulation is actually greater, as described above. To
illustrate, basal plasma insulin in human SGA infants was
shown to be reduced at 48 hours of age, similar at 1 year
of age, and greater at 3 years of age compared to infants
of normal birth weight [58]. Moreover, glucose-stimulated
insulin release was greater in these SGA infants at 1 and 3
years of age. Oversecretion of insulin in response to glucose
stimulation may promote neonatal catch-up growth in SGA
lambs [57, 86] and human infants [59, 87]t h a ti sb a s e d
largely on fat deposition.
6.Summary
The ovine model of hyperthermia-induced PI-IUGR pro-
vides a comparative system for physiological and develop-
mental research in the fetus that is applicable to humanJournal of Pregnancy 7
medicine. This model has been eﬀectively used to study
fetal adaptive responses to chronic oxygen and nutrient
deprivation during placental insuﬃciency. Fetal responses
appear primarily mediated by elevated concentrations of
stress hormones, especially catecholamines, which seemingly
inﬂuence changes in blood ﬂow, endocrine proﬁle, and
cellular metabolism to support in utero survival. However,
permanent fetal adaptations predispose oﬀspring to obesity,
type II diabetes, hypertension, and other serious metabolic
complications throughout postnatal life.
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